SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-004225
Filing Date
2023-02-07
Accepted
2023-02-07 18:14:58
Documents
2
Period of Report
2023-02-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1611
2 EX-24 DOCUMENT attachment1.htm EX-24 4392
  Complete submission text file 0000899243-23-004225.txt   7356
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Issuer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOXCEL THERAPEUTICS, INC. 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address
Kane William P Jr (Reporting) CIK: 0001813937 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38958 | Film No.: 23596459